# Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

> **NCT00189293** · PHASE4 · COMPLETED · sponsor: **MEDA Pharma GmbH & Co. KG** · enrollment: 128 (actual)

## Conditions studied

- Genital Warts

## Interventions

- **DRUG:** Imiquimod
- **OTHER:** vehicle cream

## Key facts

- **NCT ID:** NCT00189293
- **Lead sponsor:** MEDA Pharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189293, "Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00189293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*